Lunit, a Korean medical software company specializing in AI solutions, said Wednesday that its New Zealand-based subsidiary, Volpara Health Technologies—acquired in May—has secured a software supply agreement with Intermountain Health, recently recognized by Fortune Magazine and PINC AI as the largest healthcare system in the U.S.

The agreement includes Volpara's leading software products: Risk Pathways, which identifies, tracks, and manages high-risk patients for early breast cancer detection; Analytics, an AI tool designed to help mammography technologists achieve optimal positioning, compression and dose; and Scorecard, which offers insights for earlier breast cancer detection by assessing volumetric breast density percentage on a continuous scale.

Intermountain Health will utilize these tools for cancer risk assessment, breast tissue density evaluation, and improving mammography quality.

According to Lunit, this new contract between Volpara and Intermountain Health enhances Volpara’s position in the U.S. market by adding a large-scale healthcare system to its client roster. 

Intermountain Health, a nonprofit healthcare system in western U.S., operates 34 hospitals and over 400 clinics in seven states, including Utah, Idaho, and Nevada. With a workforce of approximately 58,000 employees, it is the largest private employer in Utah.

Notably, Intermountain Health is at the forefront of integrating medical AI technologies in the U.S. Recently, CB Insights, a U.S.-based AI-powered financial database platform, ranked Intermountain Health second only to Mayo Clinic on its Hospital AI Readiness Index.

This ranking is derived from a scoring model that leverages CB Insights’ datasets to assess which health systems are best prepared to navigate the rapidly evolving AI landscape.

“This agreement with Intermountain Health reaffirms Volpara's technological capabilities and solidifies our presence in the U.S. market,” said Teri Thomas, CEO of Volpara. “We are excited about the opportunity to enhance our products and develop new solutions in collaboration with Lunit, enabling us to deliver optimized solutions to healthcare providers with diverse needs.”

“This contract represents our first major milestone following the acquisition of Volpara and is especially significant due to our partnership with an innovative leader in AI like Intermountain Health,” Brandon Suh, CEO of Lunit, added.